Treatment of obesity hypertension and diabetes syndrome.
about
Management of hypertension in the cardiometabolic syndrome and diabetesObesity-Associated Hypertension: the Upcoming Phenotype in African-American Women.Treatment of hypertension in obese patients.Indole Derivatives Isolated from Brown Alga Sargassum thunbergii Inhibit Adipogenesis through AMPK Activation in 3T3-L1 Preadipocytes.Treating hypertension while protecting the vulnerable islet in the cardiometabolic syndromePrevalence of obesity in Hail region, KSA: in a comprehensive survey.Impact of the obesity epidemic on hypertension and renal disease.Optimizing blood pressure control in the obese patient.Hypertension--a treatable component of the cardiometabolic syndrome: challenges for the primary care physician.Obesity and eye diseases.Arterial hypertension in diabetes mellitus: from theory to clinical practice.Obesity-metabolic derangement preserves hemodynamics but promotes intrarenal adiposity and macrophage infiltration in swine renovascular disease.Management of arterial hypertension in obese patients.Adiponectin knockout accentuates high fat diet-induced obesity and cardiac dysfunction: role of autophagyBody mass index: a risk factor for retinopathy in type 2 diabetic patients.The effects of metformin on endogenous androgens and SHBG in women: a systematic review and meta-analysis.Proactive cardiovascular risk management versus usual care in patients with and without diabetes mellitus: CRUCIAL trial subanalysis.KCNQ1 variants associate with hypertension in type 2 diabetes and affect smooth muscle contractility in vitro.Metformin Improves Endothelial Function and Reduces Blood Pressure in Diabetic Spontaneously Hypertensive Rats Independent from Glycemia Control: Comparison to Vildagliptin.Postprandial lipemia: factoring in lipemic response for ranking foods for their healthiness.Angiotensin II Downregulates MicroRNA-145 to Regulate Kruppel-like Factor 4 and Myocardin Expression in Human Coronary Arterial Smooth Muscle Cells under High Glucose Conditions.A case-control for the association between change in weight, family history and hypertension at different ages.Altered kidney CYP2C and cyclooxygenase-2 levels are associated with obesity-related albuminuria.Blood pressure control with amlodipine add-on therapy in patients with hypertension and diabetes: results of the Amlodipine Diabetic Hypertension Efficacy Response Evaluation Trial.Blood pressure and cardiorenal responses to antihypertensive therapy in obese women.Subchronic exposure to high-dose ACE-inhibitor moexipril induces catalase activity in rat liver.MicroRNA-145 regulates disabled-2 and Wnt3a expression in cardiomyocytes under hyperglycaemia.Family with sequence similarity 13, member A modulates adipocyte insulin signaling and preserves systemic metabolic homeostasis.
P2860
Q28168564-5FCDC202-2053-41BF-A222-A1710F5E8778Q30234618-4A010DEE-38B2-4836-926D-3993F7F4AD9EQ30429298-D98B99C3-436F-436B-9214-82D261C11A3DQ33612269-FDE8E42C-B7D7-414C-A4F5-2C75D4994E70Q33840829-85C29D78-B7B4-4051-A04C-21799523AE0CQ33905276-10D67ADF-F73D-424E-B2AC-DA42A35E1691Q34226559-776A7483-B17E-4640-8094-533F7E86AFABQ34824920-EA47A0CE-718D-4228-8E7E-15B57715FBDAQ36369676-5101D746-38ED-4594-835D-D172513F6CEAQ36758799-F5F23022-E653-4358-85E6-035C0D9BDD66Q36766087-56E09228-0A05-4611-876E-535886906EE4Q37093643-4A1E5D21-9330-4E53-868D-BE5E89257030Q37119330-D4ADD34D-2DFF-4720-8874-A59A342B435AQ37228740-28EC174E-80E6-4457-9F5F-E1094E35C118Q37368103-ABA109F0-6D7B-4784-A548-12594701B071Q37379996-AAFB776C-1A25-43A9-A303-52BEA2BA5215Q38465532-168A3254-8AA8-47E8-A0ED-7930B37AF1BCQ38722721-211DF374-AB7E-4DD0-81BC-80FCC0A2106CQ41480617-8489DA31-48A0-448C-A541-0721589F2B16Q41716162-FB3421F7-0B40-41E3-90B1-323C81CBBC94Q43159975-31093FA8-787E-4C0B-94AA-5DB27B084A94Q43524651-5FD4E7DD-28CC-48A5-B3FA-8DE29D6195B0Q45038781-1C34EDB2-8838-4497-9C58-D3521824BDC0Q45931826-D999FBA2-66F0-48FF-AF78-5E1591C7641AQ46698058-DC84296A-DE43-454A-82EA-F339C70AF286Q46823662-E6800EC5-F7B7-49AB-8E7D-72BB3C08648EQ47361498-18080C6D-45CB-4947-B81D-4FCFCC26942AQ48130979-F1BAC5F7-1A78-4FAE-B3E1-937AB3EBDECC
P2860
Treatment of obesity hypertension and diabetes syndrome.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Treatment of obesity hypertension and diabetes syndrome.
@en
Treatment of obesity hypertension and diabetes syndrome.
@nl
type
label
Treatment of obesity hypertension and diabetes syndrome.
@en
Treatment of obesity hypertension and diabetes syndrome.
@nl
prefLabel
Treatment of obesity hypertension and diabetes syndrome.
@en
Treatment of obesity hypertension and diabetes syndrome.
@nl
P2093
P356
P1433
P1476
Treatment of obesity hypertension and diabetes syndrome.
@en
P2093
A B Ribeiro
M T Zanella
O Kohlmann
P304
P356
10.1161/01.HYP.38.3.705
P407
P433
P577
2001-09-01T00:00:00Z